RNCOS Online Business Research RNCOS Online Business Research Published by RNCOS by RNCOS

VIEWS: 46 PAGES: 69

Canada has established itself as one of the largest pharmaceuticals markets globally and provides tremendous opportunity for generics. In 2009, generics accounted for more than 54% prescriptions and around 24% sales of the total pharmaceutical market. Patent expiration of branded drugs, rapidly ageing population, and the government support through cost reduction measures are some of the factors that are boosting the industry growth. The market for generic drugs is expected to reach CAD 9.4 Billion in 2013 from CAD 5.5 Billion in 2009, growing at a CAGR of more than 14% during the period.

According to our latest market research report entitled “Generic Drug Market in Canada”, steps taken by the provincial governments in ensuring availability of drugs at affordable cost and billion dollar drug patent expiries will prove to be a major growth booster for the industry. Besides, the government is adopting measures that will enhance the supply proportion of generic drugs and rebates offered (to pharmacies) will augment revenue patterns.

Our report has identified that, currently, cardiovascular drugs retain the top position in terms of total prescription and the amount of prescriptions has grown by 4% in 2009 over 2008. However, oncology remained at the top position in terms of hospital sales with CAD 808.1 Million revenue in 2009. Other therapy areas such as diabetes and hypertension are expected to drive the generics market in Canada in future.

The report covers all the necessary ingredients of Canadian generics sector and distinguishes domestic market form other generics market in terms of both positive and negative ways. A notable factor of comparison that differentiates the Canadian generics market from the US and most European markets, for instance, is comparatively higher prices of generics and lower price erosion. However, the latest regulatory mechanism clearly shows that the Canadian government has been adopting measures to ensure optimum generic costs.

More Info
									RNCOS
Online Business Research
RNCOS
Online Business Research




                                               Published by




                                                RNCOS




                                     © Generic Drug Market in Canada
                                                Edition 3.0
                              All rights reserved. This publication is protected
                           by copyright. No part of it may be reproduced, stored
                           in a retrieval system or transmitted, in any form or by
                             any means, electronic mechanical, photocopying,
                               recording or otherwise without the prior written
                                        permission of the publishers.
RNCOS
Online Business Research




                                                                                                    !       "


                                                                                                #       $
                                  "                     %&       '           ()               %&        '
        #                  %* +                 (


%                                                                        ,


                                                    "        #                        -            #
                   '                                                                      #
                                                                     .                    / #




0
                                                                                  #                                   1
2 #                                                                                                     #       %& 1 1 (
3                                      0                                                                         "




$
                                                                                                                 #    %
                                                                                                                     45
                    6
    #                                 2 #                                                                   #




,                                                                "                             -
                                                    $
                            #                                                     #
                   $                        "
RNCOS
Online Business Research




                               '       #
                           #




                                   !
RNCOS
Online Business Research




                                                               Table of Contents

1.   Analyst View ........................................................................................................................................8
2.   Macroeconomic and Healthcare Factors ........................................................................................10
  2.1     Macroeconomic Indicators...........................................................................................................10
  2.2     Population Profile.........................................................................................................................12
  2.3     Age Profile ...................................................................................................................................14
  2.4     Healthcare Spending and Infrastructure......................................................................................15
3. Market Trends ....................................................................................................................................18
  3.1     Generic Drugs for Hypertension ..................................................................................................18
  3.2     Generics Getting Affordable ........................................................................................................19
  3.3     Patent Expiration .........................................................................................................................20
4. Generics Market Performance .........................................................................................................22
  4.1     Market Size and Growth ..............................................................................................................23
     4.1.1     Prescriptions ........................................................................................................................23
     4.1.2     Sales ....................................................................................................................................28
  4.2     By Province/Territories ................................................................................................................31
     4.2.1     Drug Consumption...............................................................................................................31
     4.2.2     Prescriptions ........................................................................................................................32
     4.2.3     Sales ....................................................................................................................................33
  4.3     By Distribution..............................................................................................................................34
     4.3.1     Retail Pharmacies................................................................................................................34
     4.3.2     Hospital Pharmacies............................................................................................................39
     4.3.3     Authorized and Independent Generics ................................................................................44
     4.3.4     Distribution Channels...........................................................................................................45
  4.4     By Disease...................................................................................................................................47
     4.4.1     Cardiovascular Drugs ..........................................................................................................47
     4.4.2     Psychotherapeutics .............................................................................................................49
     4.4.3     Cholesterol Agents ..............................................................................................................51
     4.4.4     Antidiabetics ........................................................................................................................53
5. Regulatory Environment...................................................................................................................55
6. Competitive Landscape ....................................................................................................................58
  6.1     Market Structure ..........................................................................................................................58
  6.2     Key Players Analysis ...................................................................................................................61
     6.2.1     Apotex..................................................................................................................................61
     6.2.2     Teva Canada Ltd. (Novopharm) ..........................................................................................63
     6.2.3     Mylan ...................................................................................................................................65
     6.2.4     Pharmascience ....................................................................................................................67




                                                                          "
RNCOS
Online Business Research




List of Figures:

Figure 2-1: Nominal GDP (Billion US$), 2007-2009....................................................................................10
Figure 2-2: Consumer Price Index (%), 2009-2013.....................................................................................11
Figure 2-3: Population (Million), 2009-2013 ................................................................................................12
Figure 2-4: Life Expectancy (Years), 2009-2013.........................................................................................13
Figure 2-5: Population Breakup by Age Group (%), 2009-2013 .................................................................14
Figure 2-6: Per Head Healthcare Spending (US$), 2009-2013 ..................................................................15
Figure 2-7: Number of Doctors (2009-2013) ...............................................................................................16
Figure 2-8: Number of Hospital Beds (per ‘000 Population), 2009-2013 ....................................................17
Figure 4-1: Pharmaceutical Sales (Billion CAD), 2009-2013 ......................................................................22
Figure 4-2: Prescriptions Dispensed in Branded Drug Market (Million), 2005-2009...................................23
Figure 4-3: Prescriptions Dispensed in Generic Drug Market (Million), 2005-2009....................................24
Figure 4-4: Share of Generic and Branded Drug by Prescription (2005-2009)...........................................25
Figure 4-5: Average Retail Price of Branded and Generic Drug (CAD), 2005-2009...................................26
Figure 4-6: Generic Drug Sales (Billion CAD), 2009-2013..........................................................................28
Figure 4-7: Branded Drug Sales (Billion CAD), 2009-2013.........................................................................29
Figure 4-8: Share of Generic and Branded Drug by Sales (2009-2013).....................................................30
Figure 4-9: Branded Drug Sales through Retail Pharmacies (Billion CAD), 2009-2013 .............................36
Figure 4-10: Generic Drug Sales through Retail Pharmacies (Billion CAD), 2009-2013 ............................37
Figure 4-11: Share of Generic and Branded Drug Sales through Retail Pharmacies (2009-2013)............38
Figure 4-12: Branded Drug Sales through Hospital Pharmacies (Billion CAD), 2009-2013 .......................41
Figure 4-13: Generic Drug Sales through Hospital Pharmacies (Billion CAD), 2009-2013 ........................42
Figure 4-14: Share of Generic and Branded Drug Sales through Hospital Pharmacies (2009-2013) ........43
Figure 4-15: Share of Independent Generic and Authorized Generic Prescriptions (2005-2008) ..............44
Figure 4-16: Generic Drug Market by Retail and Hospital Sales (%), 2009................................................46
Figure 4-17: Cardiovascular Drug Market (Billion CAD), 2005-2009 & 2013..............................................48
Figure 4-18: Psychotherapeutics Market (Billion CAD), 2005-2009 & 2013 ...............................................50
Figure 4-19: Cholesterol Agents Market (Billion CAD), 2005-2009 & 2013 ................................................52
Figure 4-20: Number of Diabetes Patients in Age Group 20-79 Years (Million), 2010 & 2030...................53
Figure 4-21: Diabetes Therapy Market (Million CAD), 2005-2009 & 2013 .................................................54




                                                                    #
RNCOS
Online Business Research




List of Tables:

Table 3-1: Patent Expiration for Some Hypertension Drugs (2012)............................................................18
Table 3-2: Patent Expiration of Key Drugs (2011).......................................................................................20
Table 4-1: Top Ten Therapy Areas by Prescription (‘000), 2009 ................................................................27
Table 4-2: Per Capita Drug Spending of Public and Private Sector by Region (CAD), 2009 .....................31
Table 4-3: Generic Drug Prescriptions Dispensed by Region (%), 2005-2009...........................................32
Table 4-4: Generic Drug Sales by Region (%), 2004 & 2006 .....................................................................33
Table 4-5: Number of Retail Pharmacies by Category (2005-2010) ...........................................................35
Table 4-6: Top Ten Therapy Areas by Hospital Sales (Million CAD), 2009 ................................................40
Table 6-1: Top Pharmaceutical Companies by Sales (Million CAD), 2009.................................................58
Table 6-2: Top Generic Drug Companies by Prescription (Million), 2007...................................................59
Table 6-3: Top Generic Drug Companies by Sales (Million CAD), 2007 ....................................................60
Table 6-4: Apotex - Strengths & Weaknesses ............................................................................................62
Table 6-5: Teva Canada Ltd. (Novopharm) - Strengths & Weaknesses.....................................................64
Table 6-6: Mylan - Strengths & Weaknesses ..............................................................................................66




                                                                  $
RNCOS
Online Business Research




    & '               () * +
                                                                                                         #
    %&            7 '                          $                               #
                                           #                                                             %
                                       .                           /




%
$                                                          "
                                                           '




$                                                                                                            #   8   #
                           %       " $             3           !                   7 %       "
                                               .                           (       / 9


                                   0                   -                                         #
                               #                                                             5


                                                       '                                 "
                                                                       #




                                                                                                                     $
                                                                                                     #
                      #                                                             $
                                  
								
To top